300683.SZ · 海特生物
China A-shares · RS rating 39 · As of 2026-10-14
| Price | 24.86 CNY |
|---|---|
| 1-day change | +0.4% |
| RS rating (overall / 1M / 3M / 12M) | 39 / 75 / 53 / 21 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 21 / 26 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -58.2% |
| Distance from 52-week high | +49.0% |
| Market cap (USD) | $517.4M |